Bioinformatics Platforms Segment to Emerge as Prominent Bioinformatics Product Segment According to our latest study, titled "Bioinformatics Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Product, Application, and Sector," the market is expected to grow from US$ 12,609.39 million in 2021 to US$ 34,749.78 million by 2028; it is expected to grow at a CAGR of 15.7% from 2022 to 2028. The report highlights the key factors driving the market and prominent players with their developments in the global bioinformatics market.

Integration of Artificial Intelligence (AI) and Machine Learning in Bioinformatics Bioinformatics and AI are playing critical roles in changing and advancing the healthcare industry. In the context of bioinformatics, AI can be used to promote clinical research and analysis that can result in the design of new drugs and vaccines, the diagnosis of diseases, and even the prediction of pandemics. One example of how AI can be used in conjunction with bioinformatics is wearable tech. Consumers are already familiar with many types of wearable techs, such as fitness trackers and watches, and make personal use of the data they collect. The wearable tech provides real-time data over a period and can help track trends and identify signs of potentially fatal health issues, such as heart disease, much quicker and more accurately than spot tests conducted in laboratories. Also, genome sequencing plays a pivotal role in medical diagnostics. Machine learning empowered DNA sequencing techniques such as next-generation sequencing has made it possible for researchers to sequence human genomes within a day compared to the traditional sanger sequencing technology, which took over a decade to sequence a human genome. The integration of AI and machine learning in bioinformatics is anticipated to be a prominent trend in the bioinformatics market during the forecast period.

Preemptive action by governments helped them flatten the infection curve in their respective countries. With the gradual recovery of countries from the COVID-19 pandemic, authorities are working on improving their resilience and creating digitally efficient healthcare systems. Furthermore, the trend of consumerization in healthcare, which provides greater authority and decision-making power to patients, is driving the paradigm shift toward value-based care in the Middle East & Africa. After the beginning of the COVID-19 pandemic, the World Bank Group committed more than US$ 157 billion to combat the effects of the crisis on health, economies, and social aspects. More than 100 countries are benefiting from the fund, which is being used to improve preparedness, protect the poor and jobs, and kickstart a climate-friendly recovery. Over 50 low- and middle-income nations, more than 50% of which are African countries, are also supported by the World Bank Group.

Based on product, the global bioinformatics market is segmented into bioinformatics platforms, knowledge management tools, and bio informative services. The bioinformatics platforms segment is likely to account for the largest market share during the forecast period. In terms of application, the market is segmented into genomics, proteomics, chemoinformatics & drug design, transcriptomics, metabolomics, and others. The genomics segment held the largest market share in 2021 and is projected to continue its dominance during the forecast period. Based on sector, the market is segmented into medical biotechnology, animal biotechnology, agricultural biotechnology, academics, environmental biotechnology, forensic biotechnology, and others. The medical biotechnology segment held the largest market share in 2021 and is likely to continue its dominance during the forecast period.

Many private organizations and government bodies worldwide are progressively investing in the field of bioinformatics. These investments have largely resulted in data and technological advancements in bioinformatics services, which have developed the quality of bioinformatics services. For instance, in 2016, the European Molecular Biology Laboratory (EMBL), an intergovernmental organization and pioneer in bioinformatics research, received funds from various organizations, such as British Heart Foundation, Biotechnology and Biological Sciences Research Council, European Molecular Biology Organization, Cancer Research UK, the European Research Council, the European Commission, the Foundation of the National Institutes of Health, Bill & Melinda Gates Foundation, the Human Frontier Science Program, International Policy Governance Organization, the Medical Research Council, the National Institutes of Health, National Science Foundation, Parkinson's UK, Research Councils UK, and Wellcome, for R&D in the field of bioinformatics.

Agilent Technologies, Inc; Biomax Informatics Ag; Bruker Corporation; Dassault Systems; Eurofins Scientific; Geneva Bioinformatics; Illumina; Perkinelmer; Qiagen; and Thermofisher Scientific, Inc. are the leading companies operating in the global bioinformatics market.

Based on geography, the global bioinformatics market is primarily segmented into North America, Europe, Asia Pacific, the Middle East & Africa (MEA), and South & Central America. The market in North America is further segmented into the US, Canada, and Mexico. The Europe market is subsegmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. The market in Asia Pacific is subsegmented into China, Japan, India, Australia, South Korea, and the Rest of APAC. The bioinformatics market in the MEA is further segmented into South Africa, Saudi Arabia, the UAE, and the Rest of the MEA. The market in South & Central America is subsegmented into Brazil, Argentina, and the Rest of South & Central America.

Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@premiummarketinsights.com